Bifacial peptide nucleic acid probes and methods of using thereof
AssigneeOhio State Innovation Foundation
InventorsDennis BONG, Shiqin MIAO, Yufeng LIANG
Life of this patent
Estimating the term…
Abstract
Disclosed herein are bifacial peptide nucleic acid probes. These probes can include a triplex hybrid forming moiety (e.g., a plurality of binding motifs disposed along a peptidyl backbone) conjugated to a prosthetic group. The triplex hybrid forming moiety can bind to a non-canonical base pairing site in a target nucleic acid via triplex hybridization. In this way, a variety of prosthetic groups (e.g., dyes, labels, reactive groups, etc.) can be selectively delivered to a target nucleic acid (e.g., in vivo, in vitro, or ex vivo).
Claims42
A compound defined by Formula I below
- wherein
- A represents a prosthetic group;
- X is absent or represents a first bivalent linking group;
- L is absent or represents a second bivalent linking group;
- n is, individually for each occurrence, an integer selected from 1 and 2;
- m is an integer selected from 2, 3, and 4;
- Z represents, individually for each occurrence, a binding motif selected from one of the following
- Q1 and Q2 individually represent —O— or —NRA—;
- Y is N, —CRB—,
- R1 is, individually for each occurrence, selected from one of the following
- R2 represents, individually for each occurrence, H, a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, or a C1-C4 haloalkyl group;
- RA represents, individually for each occurrence, H, a C1-C4 alkyl group, a C2-C4 alkenyl group, a C2-C4 alkynyl group, or a C1-C4 haloalkyl group;
- and
- RB represents, individually for each occurrence, H, halogen, methyl, or trifluoromethyl.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of detecting a target nucleic acid comprising
- contacting the target nucleic acid with a bifacial peptide nucleic acid probe comprising a triplex hybrid forming moiety conjugated to a fluorogenic dye, wherein the bifacial peptide nucleic acid probe binds to a non-canonical base pairing site in the target nucleic acid via triplex hybridization.
(canceled)
A method of selectively degrading a target protein in vivo, the method comprising
- contacting a nucleic acid with a bifacial peptide nucleic acid probe comprising a triplex hybrid forming moiety conjugated to a ubiquitin ligase ligand,
- wherein the bifacial peptide nucleic acid probe binds to a non-canonical base pairing site in the target nucleic acid via triplex hybridization;
- wherein the nucleic acid forms a ribonucleoprotein complex with the nucleic acid;
- and
- wherein the ubiquitin ligase ligand of the bifacial peptide nucleic acid probe bound to the nucleic acid directs ubiquitination of the target protein, thereby directing proteolysis of the target protein.
(canceled)
A method of selectively labeling a target protein in vivo, the method comprising
- contacting a nucleic acid with a bifacial peptide nucleic acid probe comprising a triplex hybrid forming moiety conjugated to a redox-active center, an ROS-generating center, a photoreactive center, or a catalytic center,
- wherein the bifacial peptide nucleic acid probe binds to a non-canonical base pairing site in the target nucleic acid via triplex hybridization;
- wherein the nucleic acid forms a ribonucleoprotein complex with the target protein;
- and
- wherein the redox-active center, the ROS-generating center, the photoreactive center, or the catalytic center of the bifacial peptide nucleic acid probe bound to the nucleic acid participates in a chemical reaction that results in covalent modification of the target protein, thereby labeling the target protein.
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.